TY  - JOUR
AU  - Sánchez-Martín, David
AU  - Martínez-Torrecuadrada, Jorge
AU  - Teesalu, Tambet
AU  - Sugahara, Kazuki N.
AU  - Alvarez-Cienfuegos, Ana
AU  - Ximénez-Embún, Pilar
AU  - Fernández-Periáñez, Rodrigo
AU  - Martín, M. Teresa
AU  - Molina-Privado, Irene
AU  - Ruppen-Cañás, Isabel
AU  - Blanco-Toribio, Ana
AU  - Cañamero, Marta
AU  - Cuesta Martínez, Ángel
AU  - Compte, Marta
AU  - Kremer, Leonor
AU  - Bellas, Carmen
AU  - Alonso-Camino, Vanesa
AU  - Guijarro-Muñoz, Irene
AU  - Sanz,Laura
AU  - Ruoslahti, Erkki
AU  - Alvarez-Vallina, Luis
PY  - 2013
DO  - 10.1073/pnas.1300013110
SN  - 0027-8424
UR  - https://hdl.handle.net/20.500.14352/93863
T2  - Proceedings of the National Academy of Sciences (PNAS)
AB  - Antibody cancer therapies rely on systemically accessible targets and suitable antibodies that exert a functional activity or deliver a payload to the tumor site. Here, we present proof-of-principle of in vivo selection of human antibodies in...
LA  - eng
M2  - 13791
PB  - National Academy of Sciences
TI  - Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies
TY  - journal article
VL  - 110
ER  -